Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program
Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.
wealthprofessional.ca5h
Why was AIMCo's CEO and board fired? What happens now?
The entire board of Alberta Investment Management Corporation (AIMCo) was dismissed with finance minster Nate Horner taking ...